Patient-specific Alloplastic Chin Implant Versus Computer Guided Genioplasty: Soft Tissue Assessment After One Year Follow up
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04817930 |
|
Recruitment Status :
Completed
First Posted : March 26, 2021
Last Update Posted : March 26, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Chin Microgenia | Device: Polyetheretherketone patient specific implant Device: Computer guided advancement genioplasty | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 20 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Investigator) |
| Primary Purpose: | Treatment |
| Official Title: | Patient-specific Alloplastic Chin Implant Versus Computer Guided Genioplasty: Soft Tissue Assessment After One Year Follow up |
| Actual Study Start Date : | January 1, 2019 |
| Actual Primary Completion Date : | January 1, 2020 |
| Actual Study Completion Date : | January 1, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Patient specific chin implant
A patient specific chin peek implant was used for chin augmentation
|
Device: Polyetheretherketone patient specific implant
a customized peek patient specific implant is place to augment the chin |
|
Experimental: computer guided advancement genioplasty
Computer guided advancement genioplasty using patient specific cutting and positioning guides
|
Device: Computer guided advancement genioplasty
advancement genioplasty using patient specific cutting and positioning surgical stents |
- soft tissue effect [ Time Frame: after one year ]The impact of the interventions on the soft tissue gain after one year
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients whose clinical features revealed possible correction of their facial deformity using chin surgery only
- No prior surgery involving the chin
Exclusion Criteria:
- Patients whose clinical features revealed possible correction of their facial deformity using mandibular surgeries.
- Patients with systemic diseases that carried high risk for general anesthesia.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04817930
| Egypt | |
| Faculty of Dentistry | |
| Cairo, Egypt | |
| Principal Investigator: | Mohamed Shawky | Assistant lecturer. OMFS. Cairo University |
| Responsible Party: | Mohamed Shawky, Patient-specific Alloplastic Chin Implant Versus Computer Guided Genioplasty: Soft Tissue Assessment After One Year Follow up, Cairo University |
| ClinicalTrials.gov Identifier: | NCT04817930 |
| Other Study ID Numbers: |
OMFS 3-3-6 |
| First Posted: | March 26, 2021 Key Record Dates |
| Last Update Posted: | March 26, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | intervention and effect and demographic data |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
Chin microgenia Orthognathic |

